TAK-875

fasiglifam · Takeda Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for TAK-875, covering 2012-09-13 to 2016-06-01. Get the full timeline:

Most recent: Clinical Trial Update: TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes [Phase 3]